Princeton, NJNCT07590973Now EnrollingIRB Ready

Autism Clinical Trial in Princeton, NJ

Access cutting-edge autism treatment through this clinical trial at a research site in Princeton. Study-provided care at no cost to qualified participants.

Sponsored by Blinklab Limited

Quick Self-Assessment

See if you qualify for this Princeton location

Preparing your pre-screening questions…

Expert Care in Princeton

Access autism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autism treatment provided free

Apply for This Princeton Location

Check if you qualify for this autism clinical trial in Princeton, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Princeton

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Princeton site if eligible
  4. 4Begin participation

About This Autism Study in Princeton

This observational study aims to evaluate how patterns of behavioral and sensorimotor responses measured using the BlinkLab Dx1 smartphone application relate to autism diagnoses in children ages 2 to 11. BlinkLab Dx1 is a non-invasive, smartphone-based application under development as a diagnostic aid for healthcare providers assessing autism. In this study, children who have undergone a neurodevelopmental assessment within the past 12 months will complete two short, video-based sessions using the BlinkLab Dx1 app. The app presents visual and auditory stimuli and records reflexive sensorimotor responses and patterns of repetitive behavior. Additionally, primary caregivers will answer a short questionnaire in the app about symptoms and development. Information about prior neurodevelopmental assessments, including documented DSM-5-based diagnoses from routine clinical practice, will be collected retrospectively. The study will examine how the app's neurobehavioral measurements relate to previously assigned clinical diagnoses. These paired data will be used to develop and evaluate a machine learning-based algorithm using separate training and testing datasets to assess whether patterns measured by BlinkLab Dx1 can help distinguish children with autism from children without an autism diagnosis. This study does not involve any treatment or medical intervention.

Sponsor: Blinklab Limited

Who Can Participate

Inclusion Criteria

Age: Children between 2 to 11 years old
Parent/Caregiver/Healthcare Provider Concern: The child has received a diagnostic outcome of a neurodevelopmental assessment based on DSM-5 criteria within the past 12 months.
Language Proficiency: Parents and subjects must have functional English capability in the home environment.
Informed Consent: Parents must be able to read, understand, and voluntarily sign the Informed Consent Form (ICF).
Videotaping: subjects must be willing to be videotaped during the diagnostic assessment by the BlinkLab App.

Exclusion Criteria

Device Compatibility: Parents without smartphone capabilities necessary for using the BlinkLab app.
Previous Enrollment: Subjects who have been previously enrolled in any BlinkLab clinical study.
Location of at home testing: Not being able to complete all remote at-home study sessions within the US.
History of audiogenic seizures: Participants with a known history of seizures that are triggered by auditory stimuli, including reflex or startle epilepsy provoked by sounds (audiogenic seizures), or any other form of sound-induced epilepsy.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Princeton?

Yes, this clinical trial (NCT07590973) has an active research site in Princeton, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autism Treatment Options in Princeton, NJ

If you're searching for autism treatment options in Princeton, NJ, this clinical trial (NCT07590973) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Princeton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autism clinical trials near you to find additional studies recruiting in your area.

More Autism Trials in Princeton, NJ

See all autism clinical trials recruiting in Princeton — not just this study.

Browse Autism Trials in Princeton

Browse More Trials by Condition

Ready to Join in Princeton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Princeton, NJ